Keros Therapeutics, Inc. (NASDAQ:KROS – Get Free Report) VP Annita Tanini sold 1,224 shares of Keros Therapeutics stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $10.29, for a total value of $12,594.96. Following the transaction, the vice president owned 45,144 shares of the company’s stock, valued […]

Rapport Therapeutics, Inc. (NASDAQ:RAPP – Get Free Report) insider Krishnaswamy Yeleswaram sold 404 shares of Rapport Therapeutics stock in a transaction on Wednesday, August 19th. The stock was sold at an average price of $49.90, for a total value of $20,159.60. Following the completion of the sale, the insider directly owned 246,022 shares of the […]

Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) CFO Benjamin Hohl sold 6,018 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $58.58, for a total value of $352,534.44. Following the completion of the transaction, the chief financial officer directly owned […]

Lexeo Therapeutics, Inc. (NASDAQ:LXEO – Get Free Report) CFO Louis Edward Tamayo sold 4,117 shares of the business’s stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $4.91, for a total transaction of $20,214.47. Following the completion of the transaction, the chief financial officer owned 92,907 shares […]

Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report) Director Edward Md Kaye sold 12,567 shares of the stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $32.03, for a total value of $402,521.01. Following the completion of the sale, the director directly owned 124,557 shares in the […]

Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report) insider Sean Maduck sold 3,664 shares of Corcept Therapeutics stock in a transaction dated Friday, August 14th. The shares were sold at an average price of $114.49, for a total transaction of $419,491.36. Following the sale, the insider owned 9,755 shares of the company’s stock, valued at […]

Tenaya Therapeutics, Inc. (NASDAQ:TNYA – Get Free Report) CEO Faraz Ali sold 22,232 shares of the business’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $0.71, for a total transaction of $15,784.72. Following the completion of the transaction, the chief executive officer owned 417,782 shares in […]

Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) Director Jason Rhodes sold 426,412 shares of the business’s stock in a transaction that occurred on Thursday, August 13th. The shares were sold at an average price of $26.20, for a total value of $11,171,994.40. Following the transaction, the director directly owned 751,411 shares in the company, […]

Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) CEO Kevin Koch sold 17,971 shares of Edgewise Therapeutics stock in a transaction dated Wednesday, August 12th. The stock was sold at an average price of $43.68, for a total value of $784,973.28. Following the transaction, the chief executive officer owned 52,488 shares of the company’s stock, […]